ATHE: Alterity Therapeutics Ltd insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
21 institutions reported holding $2.02M of Alterity Therapeutics Ltd on Form 13F (15 the quarter before). 6 opened a new position and 0 sold out. Shares held by institutions: +18%.
| Largest holders | Shares | Value |
|---|---|---|
| Twin Lakes Capital Management, LLC | 139,258 | $748K |
| MORGAN STANLEY | 63,065 | $339K |
| GREENLEAF TRUST | 62,000 | $333K |
| HB Wealth Management, LLC | 58,460 | $314K |
| CITADEL ADVISORS LLC | 37,597 | $202K |
| BNP PARIBAS FINANCIAL MARKETS | 10,239 | $55K |
| GAMMA Investing LLC | 2,309 | $12K |
| RHUMBLINE ADVISERS | 2,009 | $11K |
| Providence Capital Advisors, LLC | 200 | $1K |
| OSAIC HOLDINGS, INC. | 68 | $362 |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.